Date: September 12, 2019 - September 13, 2019
Location: Hyatt Regency Cambridge, 575 Memorial Drive, Cambridge, MA 02139
Focal Points and Top Enforcement Trends for Specialty Pharma and Biotech Companies and Priorities for 2020 (Keynote Panel)
September 12 | 8:30 a.m.
Brian French, Moderator
Settlements and investigations involving specialty pharmaceutical companies continue to dominate the headlines in 2019. This session explores recent settlements with the opportunity to hear from government regulators and outside counsel who are spearheading the charge against healthcare fraud and discuss the key issues impacting the industry.
The Impact of Recent FDA Guidance on Product Communications – Dramatic Change in Operations or Business as Usual?
September 13 | 8:30 a.m.
Hannah Bornstein, Presenter
During this interactive presentation, take this opportunity to weigh in on the FDA Guidance released in 2018 (“Medical Product Communications That Are Consistent with the FDA-Required Labeling” and “Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities”) and the potential effects on free speech. Gain in-depth knowledge about the guidance and then vote on whether it should affect your compliance program or not.
For more information about the conference or to register, visit the CBI conference website.